Cellzome

📍 United Kingdom🗓 Founded 2000👥 44 employees💰 Last funded Apr 2003
Pharmaceutical Manufacturing🌐 cellzome.com
Website LinkedIn
Cellzome is a privately-owned drug discovery company identifying a new generation of kinase- targeted drugs to treat inflammatory diseases. Its pipeline of small-molecule therapeutics is driven by Kinobeads™, a proprietary technology for the screening and profiling of kinases in relevant cells and tissues. Cellzome is applying its distinctive Kinobeads™ technology to the discovery and development of novel, selective, kinase inhibitors targeting key inflammatory mediators in immune receptor signalling and chemotaxis, including PI3Kγ and Zap-70.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2000
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in Cellzome?
Cellzome has 1 investors on record on gritt.io, 1 mid-stage.
When did Cellzome last raise funding?
The most recent investment in Cellzome recorded on gritt.io was in April 2003.
When was Cellzome founded?
Cellzome was founded in 2000.
What industry is Cellzome in?
Cellzome operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Cellzome based?
Cellzome is headquartered in United Kingdom.